O

OS Therapies Inc
AMEX:OSTX

Watchlist Manager
OS Therapies Inc
AMEX:OSTX
Watchlist
Price: 1.54 USD -3.75% Market Closed
Market Cap: 51.6m USD
Section:
 
Price Target
Loading...
Revenue
Loading...
Operating Income
Loading...
Net Income
Loading...

Wall Street
Price Targets

OSTX Price Targets Summary
OS Therapies Inc

There are no price targets for OSTX.
OSTX Lowest Forecast
Wall Street Target
Not Available
OSTX Average Forecast
Wall Street Target
Not Available
OSTX Highest Forecast
Wall Street Target
Not Available
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
OS Therapies Inc Competitors:
Price Targets
GILD
Gilead Sciences Inc
8% Upside
PBYI
Puma Biotechnology Inc
22% Downside
MRSN
Mersana Therapeutics Inc
18% Upside
006280
Green Cross Corp
29% Upside
GILD
Gilead Sciences Inc
8% Upside
PBYI
Puma Biotechnology Inc
22% Downside
MRSN
Mersana Therapeutics Inc
18% Upside
006280
Green Cross Corp
29% Upside
ENTA
Enanta Pharmaceuticals Inc
19% Upside
TRDA
Entrada Therapeutics Inc
65% Upside
688687
Beijing Kawin Technology Share-holding Co Ltd
92% Upside
BCYC
Bicycle Therapeutics PLC
208% Upside

Revenue
Forecast

Revenue Estimate
OS Therapies Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
OS Therapies Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
OS Therapies Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

See Also

Summary
OSTX intrinsic value, competitors valuation, and company profile.
DCF Valuation
OSTX stock valuation using Discount Cash Flow valuation method.
Relative Valuation
OSTX stock valuation using valuation multiples.
Wall Street Estimates
OSTX price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
OSTX stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is OSTX's stock price target?
Not Available

OSTX doesn't have any price targets made by Wall Street professionals.

Back to Top
ALPHA SPREAD
Follow us
Join more than 305,900+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.